Stryker (SYK) Competitors

$335.61
-1.54 (-0.46%)
(As of 04/26/2024 ET)

SYK vs. ELV, ISRG, SNY, AMGN, MDT, PFE, VRTX, CI, BSX, and BMY

Should you be buying Stryker stock or one of its competitors? The main competitors of Stryker include Elevance Health (ELV), Intuitive Surgical (ISRG), Sanofi (SNY), Amgen (AMGN), Medtronic (MDT), Pfizer (PFE), Vertex Pharmaceuticals (VRTX), The Cigna Group (CI), Boston Scientific (BSX), and Bristol-Myers Squibb (BMY). These companies are all part of the "medical" sector.

Stryker vs.

Elevance Health (NYSE:ELV) and Stryker (NYSE:SYK) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, community ranking, analyst recommendations, institutional ownership and risk.

In the previous week, Elevance Health had 24 more articles in the media than Stryker. MarketBeat recorded 38 mentions for Elevance Health and 14 mentions for Stryker. Stryker's average media sentiment score of 0.79 beat Elevance Health's score of 0.73 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
13 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
Stryker
7 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.2%. Stryker pays an annual dividend of $3.20 per share and has a dividend yield of 1.0%. Elevance Health pays out 24.6% of its earnings in the form of a dividend. Stryker pays out 38.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 13 consecutive years and Stryker has increased its dividend for 31 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and lower payout ratio.

Stryker received 52 more outperform votes than Elevance Health when rated by MarketBeat users. However, 66.61% of users gave Elevance Health an outperform vote while only 64.43% of users gave Stryker an outperform vote.

CompanyUnderperformOutperform
Elevance HealthOutperform Votes
830
66.61%
Underperform Votes
416
33.39%
StrykerOutperform Votes
882
64.43%
Underperform Votes
487
35.57%

Stryker has a net margin of 15.44% compared to Stryker's net margin of 3.64%. Elevance Health's return on equity of 22.99% beat Stryker's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health3.64% 20.62% 7.35%
Stryker 15.44%22.99%10.69%

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 77.1% of Stryker shares are held by institutional investors. 0.4% of Elevance Health shares are held by company insiders. Comparatively, 5.9% of Stryker shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Elevance Health has higher revenue and earnings than Stryker. Elevance Health is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$171.34B0.73$5.99B$26.4620.30
Stryker$20.50B6.23$3.17B$8.2540.68

Elevance Health has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, Stryker has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500.

Elevance Health presently has a consensus price target of $587.42, suggesting a potential upside of 9.34%. Stryker has a consensus price target of $340.67, suggesting a potential upside of 1.51%. Given Stryker's stronger consensus rating and higher probable upside, equities research analysts plainly believe Elevance Health is more favorable than Stryker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.92
Stryker
0 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.77

Summary

Elevance Health beats Stryker on 12 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SYK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SYK vs. The Competition

MetricStrykerSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$127.69B$3.82B$4.95B$17.54B
Dividend Yield0.95%2.19%2.92%3.54%
P/E Ratio40.6810.94145.6521.72
Price / Sales6.2361.712,368.1810.95
Price / Cash25.0343.3148.1917.84
Price / Book6.864.184.624.87
Net Income$3.17B$4.71M$103.92M$964.49M
7 Day Performance3.13%1.34%0.74%1.90%
1 Month Performance-6.22%-8.90%-8.16%-3.71%
1 Year Performance12.00%17.25%3.70%93.11%

Stryker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELV
Elevance Health
4.4336 of 5 stars
$532.92
+0.1%
$587.64
+10.3%
+15.4%$123.86B$171.34B20.14104,900Dividend Announcement
Analyst Report
Insider Selling
Analyst Revision
News Coverage
ISRG
Intuitive Surgical
4.7791 of 5 stars
$377.08
+2.2%
$396.17
+5.1%
+26.8%$133.66B$7.12B68.0713,676Insider Selling
Short Interest ↓
SNY
Sanofi
3.4115 of 5 stars
$47.69
+1.1%
$55.00
+15.3%
-12.4%$120.64B$46.61B20.2186,088Short Interest ↓
Analyst Revision
News Coverage
AMGN
Amgen
4.9213 of 5 stars
$273.54
+0.6%
$296.95
+8.6%
+12.3%$146.72B$28.19B21.9026,700Upcoming Earnings
MDT
Medtronic
4.6706 of 5 stars
$81.28
+0.9%
$94.91
+16.8%
-12.7%$106.98B$32.32B25.8995,000
PFE
Pfizer
4.9751 of 5 stars
$26.32
+0.2%
$36.33
+38.0%
-34.4%$149.04B$58.50B73.1188,000Upcoming Earnings
Dividend Announcement
News Coverage
VRTX
Vertex Pharmaceuticals
4.2757 of 5 stars
$404.91
+1.2%
$429.45
+6.1%
+17.1%$104.65B$9.87B29.155,400
CI
The Cigna Group
4.8506 of 5 stars
$352.70
-0.1%
$362.14
+2.7%
+41.6%$103.12B$195.27B20.2870,325Upcoming Earnings
Dividend Announcement
Short Interest ↓
News Coverage
BSX
Boston Scientific
4.458 of 5 stars
$68.99
+1.4%
$68.50
-0.7%
+40.6%$101.22B$14.24B64.4848,000Analyst Report
BMY
Bristol-Myers Squibb
4.9172 of 5 stars
$49.00
-0.3%
$61.18
+24.8%
-33.7%$99.59B$45.01B12.6934,100Earnings Report
Analyst Report
Analyst Revision
News Coverage

Related Companies and Tools

This page (NYSE:SYK) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners